SPY326.54-3.44 -1.04%
DIA265.06-1.53 -0.57%
IXIC10,911.59-274.00 -2.45%

Maxim Group Initiates Coverage On Cellectar Biosciences with Buy Rating, Announces Price Target of $3

Maxim Group analyst Jason McCarthy initiates coverage on Cellectar Biosciences (NASDAQ:CLRB) with a Buy rating and announces Price Target of $3.

Benzinga · 06/23/2020 16:24
Maxim Group analyst Jason McCarthy initiates coverage on Cellectar Biosciences (NASDAQ: CLRB) with a Buy rating and announces Price Target of $3.